£170.99

Horizons in Cancer Research. Volume 81 (Horizons in Cancer Research)

Price data last checked 26 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£171 today · previous high £171 · all-time low £169

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 65 days · 65 data points (no recent data)

Historical
Generating forecast…
£170.99 £169.34 £169.70 £170.06 £170.42 £170.78 £171.14 11 June 2026 27 June 2026 13 July 2026 29 July 2026 14 August 2026

Price Distribution

Price distribution over 65 days • 2 price levels

Days at Price
Current Price
61 days 4 days · current 0 15 31 46 61 £169 £171 Days at Price

Price Analysis

Most common price: £169 (61 days, 93.8%)

Price range: £169 - £171

Price levels: 2 different prices over 65 days

Description

This edited volume presents seven chapters detailing recent progress in the field of cancer research. Chapter One explores the application of robotic surgery to radical cystectomy, highlighting patient selection, surgical approach, perioperative and oncologic outcomes as well as some areas of controversy in the literature. Chapter Two describes the principles of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy procedures with its potential risks for patients and staff. Chapter Three discusses findings related to ISG15 and protein ISGylation, and their association with interferon signaling in cancer. Chapter Four describes the potential for MCF-7 cells to curb or counteract breast cancer. Chapter Five discusses the potential of emerging technologies in breast conserving treatment. Chapter Six reviews the current literature surrounding the basis of employing the immune system for the treatment of the various non-melanoma skin cancers (NMSC), discusses approved immunotherapies for each type of NMSC as well as indications for use, and synthesizes ongoing investigational studies of immunomodulatory agents for these diseases. Finally, Chapter Seven discusses the use of gene therapy in management of squamous cell carcinoma.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Horizons in Cancer Research: v. 41: Volume 41
91% match

Horizons in Cancer Research: v. 41: Volume 41

£128.24 09 Aug 2026
Horizons in Cancer Research. Volume 82 (Horizons in Cancer Research)
89% match

Horizons in Cancer Research. Volume 82 (Horizons in Cancer Research)

£221.99 12 Aug 2026
Advances in Cancer Research (Volume 80)
89% match

Advances in Cancer Research (Volume 80)

Elsevier

£115.00 12 Aug 2026
Advances in Health and Disease. Volume 41 (Advances in Health and Disease)
87% match

Advances in Health and Disease. Volume 41 (Advances in Health and Disease)

£169.50 14 Aug 2026
Advances In Cancer Research: Volume 87
87% match

Advances In Cancer Research: Volume 87

Academic Press

£115.00 06 Aug 2026
Advances in Cancer Research Volume 71
87% match

Advances in Cancer Research Volume 71

Academic Press

£110.00 06 Aug 2026
Advances in Cancer Research, Volume 88: Volume 88
86% match

Advances in Cancer Research, Volume 88: Volume 88

Academic Press

£115.00 06 Aug 2026
Targeted Therapies in Cancer: An Update (Cancer Etiology, Diagnosis and Treatments)
86% match

Targeted Therapies in Cancer: An Update (Cancer Etiology, Diagnosis and Treatments)

£89.16 05 Aug 2026
Advances in Engineering Research. Volume 41 (Advances in Engineering Research)
86% match

Advances in Engineering Research. Volume 41 (Advances in Engineering Research)

£221.99 30 Jul 2026
New Research on Hematological Malignancies (Cancer Etiology, Diagnosis and Treatments)
86% match

New Research on Hematological Malignancies (Cancer Etiology, Diagnosis and Treatments)

£57.75 10 Aug 2026
Advances in Cancer Research, Volume 90: Volume 90
86% match

Advances in Cancer Research, Volume 90: Volume 90

Academic Press

£115.00 06 Aug 2026
Agricultural Research Updates. Volume 41 (Agricultural Research Updates)
86% match

Agricultural Research Updates. Volume 41 (Agricultural Research Updates)

£169.50 09 Aug 2026
Frontiers In Clinical Drug Research - Anti-Cancer Agents: Volume 8
86% match

Frontiers In Clinical Drug Research - Anti-Cancer Agents: Volume 8

£75.17 14 Aug 2026
Horizons in Computer Science Research. Volume 17 (Horizons in Computer Science)
86% match

Horizons in Computer Science Research. Volume 17 (Horizons in Computer Science)

£266.99 13 Aug 2026
Combination Therapies and their Effectiveness in Breast Cancer Treatment (Cancer Etiology, Diagnosis and Treatments)
85% match

Combination Therapies and their Effectiveness in Breast Cancer Treatment (Cancer Etiology, Diagnosis and Treatments)

£180.66 14 Jul 2026
Cancers
85% match

Cancers

£56.00 30 Jun 2026
Advances in Cancer Research
85% match

Advances in Cancer Research

Academic Press

£110.00 10 Aug 2026
Advances in Cancer Research
85% match

Advances in Cancer Research

Academic Press

£110.00 13 Aug 2026
Advances in Cancer Research
85% match

Advances in Cancer Research

Academic Press

£110.00 10 Aug 2026
Advances in Cancer Research
85% match

Advances in Cancer Research

Academic Press

£104.00 06 Aug 2026
Advances in Cancer Research
85% match

Advances in Cancer Research

Academic Press

£104.00 06 Aug 2026
Advances in Cancer Drug Targets: Volume 1
85% match

Advances in Cancer Drug Targets: Volume 1

£77.33 10 Aug 2026
Advances in Sociology Research. Volume 31
85% match

Advances in Sociology Research. Volume 31

£169.49 09 Aug 2026
Advances in Cancer Drug Targets
85% match

Advances in Cancer Drug Targets

£79.95 10 Aug 2026